Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/12/2014 | WO2014088056A1 Method for storing leuco type chromogen-containing aqueous solution |
06/12/2014 | WO2014088040A1 Method for treating mesothelioma |
06/12/2014 | WO2014087863A1 Anti-folr1 antibody |
06/12/2014 | WO2014087810A1 Anti-vasohibin 2 antibody |
06/12/2014 | WO2014087802A1 Method for suppressing nonspecific signals from contaminants in an immunoassay using surface plasmon-field enhanced fluorescence spectroscopy (spfs) |
06/12/2014 | WO2014087435A1 Diagnostic method of autoimmune diseases |
06/12/2014 | WO2014087374A1 Monitoring method and probe of the alcoholic fermentation with spectroscopy uv-vis-swnir |
06/12/2014 | WO2014087361A1 In silico prediction of enhanced nutrient content in plants by metabolic modelling |
06/12/2014 | WO2014087360A1 Method for detection of kerosene adulteration with extrinsic marker in gasoline, aviation turbine fuel and diesel |
06/12/2014 | WO2014087359A1 Methodology for detection of kerosene adulteration in gasoline, motor spirit, aviation turbine fuel and diesel with intrinsic marker |
06/12/2014 | WO2014087191A1 Method for selecting a pool of molecules |
06/12/2014 | WO2014087137A1 Device including biosensor and holder |
06/12/2014 | WO2014087125A1 Method and apparatus for monitoring gas concentration |
06/12/2014 | WO2014087100A1 Use of grafted biotin for metering metals in a solution and metering kit |
06/12/2014 | WO2014087090A1 System for measuring an oil-retention volume in a lubrication circuit |
06/12/2014 | WO2014087018A1 Markers for responsiveness to an inhibitor of flt3 |
06/12/2014 | WO2014086979A1 Method for measuring coagulation of blood samples using viscoelastic tests (vet) |
06/12/2014 | WO2014086956A2 Valving system for use in centrifugal microfluidic platforms |
06/12/2014 | WO2014086951A1 Reference and normalisation method for use with bead-based immunoassays in a microfluidic disc |
06/12/2014 | WO2014086934A1 Diagnosis of cystic fibrosis |
06/12/2014 | WO2014086916A1 Anti-mif antibody cell migration assay |
06/12/2014 | WO2014086833A1 Biomarkers in the selection of therapy of heart failure |
06/12/2014 | WO2014086765A2 Organized immune response in cancer |
06/12/2014 | WO2014086605A1 Isovalerylglycine as biomarker for the predisposition for weight gain and obesity |
06/12/2014 | WO2014086604A1 Trimethylamine-n-oxide as biomarker for the predisposition for weight gain and obesity |
06/12/2014 | WO2014086603A1 Hexanoylglycine as biomarker for the predisposition for weight gain and obesity |
06/12/2014 | WO2014086486A2 Heat treatment monitoring system |
06/12/2014 | WO2014086455A1 Device for connecting a high-pressure sensor |
06/12/2014 | WO2014086361A1 Method of diagnosing galactosemia in neonatal screening |
06/12/2014 | WO2014086335A1 Method and arrangement for non-invasive, non-destructive identification of molecule-specific and/or biological properties of an internal structure of a biological examination item through an optically impenetrable barrier |
06/12/2014 | WO2014086243A1 Mirna molecule for negatively regulating type i interferon pathway and use thereof |
06/12/2014 | WO2014085940A1 Characterization of the hairiness length distribution of a yarn |
06/12/2014 | WO2014085939A1 Determining the hairiness lengths on a yarn |
06/12/2014 | WO2014085931A1 Automated ultra-filtration system |
06/12/2014 | WO2014085926A1 Pressure assisted lateral flow diagnostic device |
06/12/2014 | WO2014085915A1 A method for using xin protein to assess the degree of muscle damage |
06/12/2014 | WO2014085909A1 Methods and kits for monitoring response to radiation therapies in cancer |
06/12/2014 | WO2014085902A1 Reduction of fouling in high pressure reactors |
06/12/2014 | WO2014085852A1 A material dispenser for use in an analysis process of a mineral sample |
06/12/2014 | WO2014070564A8 Characterization of rock and other samples by process and system for the preparation of samples using castable mounting materials |
06/12/2014 | WO2014064443A3 Formation of array of membranes and apparatus therefor |
06/12/2014 | WO2014064437A3 Fluid sensor comprising a composite cavity member |
06/12/2014 | WO2014064436A3 Waveguide sensor with a dielectric sample tube and with a dielectric member filling the waveguide |
06/12/2014 | WO2014062069A4 Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapy |
06/12/2014 | WO2014036440A3 Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia |
06/12/2014 | WO2014031859A9 Compositions and methods relating to blood-based biomarkers of breast cancer |
06/12/2014 | WO2014018886A9 Electronic measurements of monolayers following homogeneous reactions of their components |
06/12/2014 | WO2014011261A3 System and method for optical detection using capillary action |
06/12/2014 | WO2014009384A3 System and method for identifying and distinguishing materials, method for identifying or distinguishing materials, and measuring device for recording material properties of materials |
06/12/2014 | WO2014004990A3 Methods for determining drug efficacy using cereblon-associated proteins |
06/12/2014 | WO2013188699A9 Compositions, methods and devices for activating an immune response |
06/12/2014 | WO2013131621A8 Prediction of outcome in patients with chronic obstructive pulmonary disease |
06/12/2014 | WO2013061223A3 Tablet testing device |
06/12/2014 | US20140165222 High affinity sumo traps |
06/12/2014 | US20140163925 Anti-terrorism water quality monitoring system |
06/12/2014 | US20140163906 Method for estimating vulcanization degree of rubber compound |
06/12/2014 | US20140163118 Expression Signatures of Genes and Gene Networks Associated with Skin Aging |
06/12/2014 | US20140163075 Modulation of the ubiquitin-proteasome system (ups) |
06/12/2014 | US20140163034 Inhibitors of anandamide transport and their therapeutic uses |
06/12/2014 | US20140163021 FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction |
06/12/2014 | US20140162993 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists |
06/12/2014 | US20140162968 Method for screening of agent for treating or preventing obesity |
06/12/2014 | US20140162949 Treatment with human growth hormone analogues |
06/12/2014 | US20140162947 Kruppel-like Factor 10 (KLF10) as a Biomarker of Endothelial Progenitor Cell Dysfunction |
06/12/2014 | US20140162936 New chymase binding compounds and medical uses thereof |
06/12/2014 | US20140162908 Bio-chip |
06/12/2014 | US20140162905 Evaporative edge lithography of a liposomal drug microarray for cell migration assays |
06/12/2014 | US20140162903 Metabolite Biomarkers For Forecasting The Outcome of Preoperative Chemotherapy For Breast Cancer Treatment |
06/12/2014 | US20140162900 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
06/12/2014 | US20140162893 Aptamer Coated Measurement and Reference Electrodes and Methods Using Same for Biomarker Detection |
06/12/2014 | US20140162891 Methods and materials for detection, diagnosis and management of ovarian cancer |
06/12/2014 | US20140162889 Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer |
06/12/2014 | US20140162378 Method for detecting target particle |
06/12/2014 | US20140162377 Lactoferrin Fragments And Use Thereof |
06/12/2014 | US20140162376 Compositions and methods to assess the capacity of hdl to support reverse cholesterol transport |
06/12/2014 | US20140162375 Carbon based biosensors and processes of manufacturing the same |
06/12/2014 | US20140162374 Method for holding multiple types of diagnostic test consumables in a random access single container |
06/12/2014 | US20140162371 Methods for detecting vitamin d metabolites by mass spectrometry |
06/12/2014 | US20140162370 Urine biomarkers for necrotizing enterocolitis and sepsis |
06/12/2014 | US20140162368 Portable Nanoparticle Based Assay For Rapid Detection of Food Antioxidants (NanoCerac) |
06/12/2014 | US20140162358 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors |
06/12/2014 | US20140162348 Electrical measuring container, electrical measuring apparatus and electrical measuring method |
06/12/2014 | US20140162309 Arsenical Fluorescent Agents and Assays |
06/12/2014 | US20140162305 Patient In Vivo Gut Diagnostic and Treatment Tool |
06/12/2014 | US20140162304 Macrophage hazardous material detection |
06/12/2014 | US20140162297 Anti-carbamylated protein antibodies and the risk for arthritis |
06/12/2014 | US20140162295 Method and Biomarker for Detecting of Acute Kidney Injury |
06/12/2014 | US20140162294 Methods and compositions for assaying vitamin d |
06/12/2014 | US20140162293 Gene coded for a mhc class i molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a t cell frequency |
06/12/2014 | US20140162291 In vitro method using human skin for evaluating the influence of abc transporters |
06/12/2014 | US20140162290 Probe for detecting dead cell |
06/12/2014 | US20140162289 Identifying molecules modulating protein-protein interactions using protease activated reporters |
06/12/2014 | US20140162288 Biomarker for replicative senescence |
06/12/2014 | US20140162287 Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine |
06/12/2014 | US20140162286 Method for the detection of enzymatic activity with magnetically functionalized substrates |
06/12/2014 | US20140162285 Methods of Modulating Vesicular Trafficking |
06/12/2014 | US20140162284 In Vitro Assay Method Using Immunological Technique |
06/12/2014 | US20140162283 Compositions and Methods for Detecting Mycobacterium |
06/12/2014 | US20140162282 Methods for determining drug efficacy using cereblon-associated proteins |
06/12/2014 | US20140162280 Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles |